Venous thromboembolism – multifactorial disease. Case report 
of a 36-year-old woman

Venous thromboembolism is the health and life- threatening state. This pathology is the third most common cardiovascular disease – after myocardial infarction and stroke - among general population. Venous thromboembolism is condition that includes both deep vein thrombosis and pulmonary embolism. The main symptoms reported by patients are dyspnoea, chest pain, cough, unilateral extremity swelling and unilateral leg pain. In most patients deterioration of health withdraw after treatment and never again comes back but in some people recurrence of venous thromboembolism is reported. We describe a case report of 36-years-old woman affected by polycystic ovary syndrome which was taking combined oral contraceptive in whom venous thromboembolism was diagnosed.

REFERENCES (14)

Okoroh EM, Hooper WC, Atrash HK, Yusuf HR, Boulet SL. Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003–2008. Am J Obstet Gynecol 2012; 207: 377.e1-377.e8.

Google Scholar

Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35: 3033-3073.

Google Scholar

Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107 (23 suppl 1): I-9.

Google Scholar

Piazza G. Beyond Virchow’s Triad: does cardiovascular inflammation explain the recurrent nature of venous thromboembolism? Vasc Med 2015; 20: 102-104.

Google Scholar

Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis 2016; 41: 3-14.

Google Scholar

Hugon-Rodin J, Gompel A, Plu-Bureau G. Epidemiology of hormonal contraceptives-related venous thromboembolism. Eur J Endocrinol 2014; 171: R221-R230.

Google Scholar

Sitruk-Ware R. Pharmacology of different progestogens: the special case of drospirenone. Climacteric 2005; 8 supl: 4-12.

Google Scholar

Stegeman BH, de Bastos M, Rosendaal FR, van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ 2013; 347: f5298.

Google Scholar

Bateson D, Butcher BE, Donovan C, Farrell L, Kovacs G, Mezzini T, Baber R. Risk of venous thromboembolism in women taking the combined oral contraceptive: a systematic review and meta-analysis. Austral Fam Phys 2016; 45: 59-64.

Google Scholar

10.

Dinger J, Möhner S, Heinemann K. Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives. Contraception 2016; 93: 378-385.

Google Scholar

11.

van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJM, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 2009; 339: b2921.

Google Scholar

12.

Vinogradova Y, Coupland C, Hippisley-Cox J. Exposure to combined oral contraceptives and risk of venous thromboembolism: a protocol for nested case-control studies using the QResearch and the CPRD databases. BMJ Open 2015; 4: e004499.

Google Scholar

13.

Eichinger S, Evers JLH, Glasier A, La Vecchia C, Martinelli I, Skouby S, Gianaroli L. Venous thromboembolism in women: a specific reproductive health risk. Hum Reprod Update 2013; 19: 471-482.

Google Scholar

14.

Bird ST, Hartzema AG, Brophy JM, Etminan M, Delaney JA. Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. Canad Med Assoc J 2013; 185: E115-E120.

Google Scholar

Submit your paper

eISSN:	2300-6722
ISSN:	1899-1874